Exponent, Inc. Third Quarter of Fiscal Year 2026 Financial Results Conference Call - EXPONENT INC

Financial Performance:

• Total revenues increased 18% year-over-year to $173.7 million; net revenues (excluding reimbursements) grew 12% to $153.1 million.
• Net income rose 10% to $30.9 million; diluted EPS increased 16% to $0.64.
• EBITDA grew 16% to $45 million, with EBITDA margin expanding to 29.4% of net revenues from 28.3% in the prior period.
• Utilization reached 76.7% (up from 74.1%), driven by broad-based demand; average realized rates increased approximately 4%.
• Billable hours totaled approximately 405,000 (up 8%); average technical FTEs increased 4% to 1,016.
• Used $171 million for stock repurchases over the trailing 12 months, reducing diluted shares by 5%.
• Tax rate was 28% (up from 27.4%); deferred compensation gains were immaterial ($159k vs $7M prior year).

Guidance and Future Outlook:

• Raised full-year 2026 net revenue growth guidance to 10–11% and EBITDA margin to 28.0–28.3% (previously lower).
• Q4 2026 net revenue growth guidance is 8–10%, with EBITDA margin expected at 26.3–26.8%.
• Full-year 2026 utilization expected at 73.5–74%; Q4 utilization guided at 69–70% due to seasonal holidays/vacations.
• Realized rate growth expected at 3.7–4% for the full year; Q4 rate growth at 3–3.5%.
• Full-year stock-based compensation guided at $28.1–28.4 million; G&A expenses at $28.1–28.6 million.
• Capital expenditures for 2026 expected at $10–12 million.

Business Segments and Product Lines:

• Engineering and Scientific segment (85% of net revenue) grew 13%, driven by user research in health, dynamic real-world environments, and dispute services in chemicals and transportation.
• Environmental and Health segment (15% of net revenue) grew 3%, fueled by projects assessing chemical effects on health and the environment.
• User research work is expanding into complex areas like wearable device health analytics, sensory perception, and AI-generated material safety.
• Reactive dispute and failure analysis work is growing in consumer products, chemicals, and transportation (specifically advanced driver assistance systems).
• Hiring focus includes human factors, biomechanics, thermal scientists, polymer experts, metallurgists, and health/environmental specialists (e.g., PFAS, emerging chemicals).

Market and Competitive Landscape:

• Core market driver is the convergence of technology, infrastructure, and humans, necessitating safety and reliability verification in real-world conditions.
• AI is estimated to be a direct element in 15–20% of current business, expanding across all five layers of the AI stack (from hardware/data centers to applications).
• Demand is increasing for "explainability" and trust in AI decisions when products fail or behave unexpectedly in the physical world.
• Competition is intensifying in areas requiring multidisciplinary expertise (e.g., thermal + mechanical + materials for AI cooling systems).
• The company leverages a 60-year history in risk management, autonomous vehicles, and utility risk as a differentiator against newer entrants.

Risks and Challenges:

• Reimbursable expenses fluctuate based on project mix, causing total revenue growth to outpace net revenue growth.
• Share repurchases reduce interest income; future tax rates may rise (28.5% projected for 2027).
• Seasonal utilization drops in Q4 due to holidays and vacations.
• AI liability and dispute resolution are in early stages; full exposure to judicial disputes regarding AI failures has not yet fully materialized.
• Dependency on attracting top-tier talent (PhDs) to maintain capability in emerging, complex fields.

Management Commentary and Tone:

• Management expressed high confidence in the long-term growth framework, citing strengthening demand drivers for safety, reliability, and infrastructure.
• Tone emphasized Exponent's unique "integrated ecosystem" of scientists and engineers to solve hard, high-consequence questions that competitors cannot address.
• CEO Catherine Corrigan highlighted that the market is growing because technology questions are getting harder, not easier.
• President John Pye noted that AI work is moving from hypothetical to real projects, focusing on data quality and real-world testing.
• CFO Eric Anderson confirmed robust business flow without structural calendar distortions driving Q3 results.

Analyst Questions and Answers:

• Utilization Drivers: Eric clarified Q3 utilization was driven by broad demand (consumer products, chemicals, transportation) rather than calendar effects, noting a large Q2 project (4% of rev) normalized to 2.5% in Q3.
• AI Growth Trajectory: John stated AI work existed 5–10 years ago (e.g., autonomous vehicles, utility risk) and is now expanding; future growth expected to accelerate.
• Proactive vs. Reactive Growth: Proactive business grew in the high teens; reactive business grew in the high single digits (on a tough prior-year comp).
• AI in Disputes: John confirmed AI-related reactive work exists now (e.g., ADAS failures, data center fires), though widespread judicial disputes are still emerging, with medical devices as a potential next ramp.
• Hiring Strategy: Andrew asked about headcount vs. pricing; management indicated they are ramping up recruiting (university and lateral) to match demand, with pricing and specific headcount details to follow.
• Capital Allocation: Eric reiterated a consistent philosophy of paying dividends and buying back shares on price pullbacks, maintaining $50M authorization.

Other Key Points:

• The company recently held its first Investor Day in Phoenix, focusing on the "convergence of technology, infrastructure, and humans."
• A specific large project that contributed 4% of Q2 revenue is expected to wind down to under 1% in Q4.
• Deferred compensation losses/gains are offset to miscellaneous income and do not impact the bottom line.
• Management highlighted the increasing complexity of single product safety investigations requiring cross-disciplinary teams (e.g., thermal, mechanical, materials).
• The company anticipates no additional tax benefits from share-based awards for the remainder of 2026.